Nature, Published online: 24 September 2025; doi:10.1038/s41586-025-09507-9

CELLFIE, a CRISPR platform for optimizing cell-based immunotherapies, identifies gene knockouts that enhance CAR T cell efficacy using in vitro and in vivo screens.


From Nature via this RSS feed